Bitcoin extended its decline on Friday, dipping below $100,000 for the first time in six months and leaving investors questioning whether the latest crypto bull run has reached its limits. ...
Jamf to go private in a $2.2B all-cash deal with Francisco Partners at $13.05/share—a 50% premium. The move boosts financial flexibility for Jamf’s SaaS and security growth strategy. ...
Ondas Eyes Sentry CS: How This Small-Cap Deal Could Reshape The Battlefield Communications Landscape
Ondas eyes Sentry Cellular in a bold bid to enter military-grade 5G—aiming to leap from industrial wireless to defense tech, tapping DoD demand for secure private networks. ...
Getty Images partners with Perplexity, licensing its vast image library. The deal boosts Getty’s AI monetization and strengthens content attribution amid shifting copyright and merger dynamics. ...
TriArtisan-led group to take Denny’s private at $6.25 per share, 52% premium signaling strategic value in its brand, franchise network, & turnaround potential within the evolving casual dining market. ...
Amazon (AMZN) is surging again as investors investors speculate that the company’s long-awaited cloud turnaround and new artificial intelligence partnerships could reignite its growth story. ...
Cadre to acquire TYR Tactical for $175M in cash and stock, expanding into defense gear. The deal adds $92.6M revenue, boosts margins, and strengthens Cadre’s global footprint by H1 2026. ...
CYH advances divestiture strategy, selling 3 PA hospitals to Tenor Health Foundation. Deal aligns with leverage reduction and turnaround plan, spotlighting CYH’s value in underserved markets. ...
Bitcoin extended losses on Tuesday, tumbling more than 5% to trade near $101,000 as rising selling pressure and stalled liquidity from the U.S. government shutdown weighed on the cryptocurrency. ...
Big tech companies are ramping up their AI investments at a rapid pace, and the scale of the outlays suggests that even if the market is in bubble territory, there ...
Meta’s (META) latest earnings report sent shockwaves through Wall Street on Thursday, with shares falling more than 10% as investors balked at the company’s growing AI investments. ...
Avadel Pharmaceuticals’ $2.1B acquisition by Alkermes underscores Lumryz’s strong growth and profitability, with added upside tied to FDA approval for a new sleep disorder indication. ...